Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8641182Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2025
Linked Award Amount
$694.7K
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#23,536
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Ningjun Li as a PI. Multi-PI records show the full award amount for context.
- 5R01DK140219-02R01Renal acid ceramidase-S1P pathway in salt-sensitive hypertension$467.5Kaward amount
- 1R21CA289216-01A1R21Inhibition of diacylglycerol lipase α as a novel strategy to mitigate the nephrotoxicity of cisplatin$227.2Kaward amount
Award organization
Organizations that administered FY2025 awards listing Ningjun Li as a PI.
FY2025 award administered by Virginia Commonwealth University (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardVirginia Commonwealth University
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder